(Total Views: 397)
Posted On: 05/11/2022 11:07:09 PM
Post# of 1418
Some of Gerald's statements today.
Testing is steady, we are mid validation to expand our panel which will drive rev expansion. Sooner or later we are going to see people wave the white flag on the rapid COVID tests. Then the damn will break. In meantime, we are also preparing Long Haul offering
We agree on the need for Tollovir EUA. With that said I’m hearing a whole lot more from customers than what’s on Twitter because many don’t want to be trolled/harassed. Don’t forget the majority is usually silent
Dr. Mitchell isn’t driving Tollovir, Dr. Rojas is driving us forward. We are bringing in some heavy heavy hitters to help us with FDA for Tollovir. I’ll update more soon with a full update
Yes, we are working on the Reg A filing to fund it. No more notes into AMBS.
Working on 3CL funding. That’s the next major funding event, we are looking to minimize Todos dilution now that we’ve hit the initial valuation milestone at 3CL. Getting TolloTest valued now as well
Never said that. Only God knows what the market will do. It’s been mean to us, maybe one day it will be nice. It hasn’t been for a lack of good news. One of the news items might hit as we get closer to regulatory activity on hospitalized and clinical milestones in LC
On this thread
https://twitter.com/G_Commish/status/15244595...g&s=19
Testing is steady, we are mid validation to expand our panel which will drive rev expansion. Sooner or later we are going to see people wave the white flag on the rapid COVID tests. Then the damn will break. In meantime, we are also preparing Long Haul offering
We agree on the need for Tollovir EUA. With that said I’m hearing a whole lot more from customers than what’s on Twitter because many don’t want to be trolled/harassed. Don’t forget the majority is usually silent
Dr. Mitchell isn’t driving Tollovir, Dr. Rojas is driving us forward. We are bringing in some heavy heavy hitters to help us with FDA for Tollovir. I’ll update more soon with a full update
Yes, we are working on the Reg A filing to fund it. No more notes into AMBS.
Working on 3CL funding. That’s the next major funding event, we are looking to minimize Todos dilution now that we’ve hit the initial valuation milestone at 3CL. Getting TolloTest valued now as well
Never said that. Only God knows what the market will do. It’s been mean to us, maybe one day it will be nice. It hasn’t been for a lack of good news. One of the news items might hit as we get closer to regulatory activity on hospitalized and clinical milestones in LC
On this thread
https://twitter.com/G_Commish/status/15244595...g&s=19
(2)
(0)
